Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters.

@article{KemnyBeke2011IncreasedPO,
  title={Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters.},
  author={{\'A}d{\'a}m Kem{\'e}ny-Beke and Rudolf Gesztelyi and N{\'o}ra Bodn{\'a}r and Judit Zsuga and Gy{\"o}rgy Kerekes and Mikl{\'o}s Zsuga and Bernadett Biri and S{\'a}ndor K{\'e}ki and P{\'e}ter Szodoray and Andr{\'a}s Berta and Zolt{\'a}n Szekanecz and S{\'a}ndor Sz{\'a}nt{\'o}},
  journal={Joint, bone, spine : revue du rhumatisme},
  year={2011},
  volume={78 2},
  pages={184-7}
}
OBJECTIVE Asymmetric dimethylarginine (ADMA) has been associated with atherosclerosis, vascular diseases and, recently, also with arthritis including rheumatoid arthritis (RA) and ankylosing spondylitis (AS). METHODS Serum ADMA, arginine and symmetric dimethylarginine (SDMA) levels were assessed by liquid chromatography in 61 AS and 26 osteoarthritis (OA) patients with no known cardiovascular disease. RESULTS Serum ADMA levels were significantly increased in AS compared to OA patients (0.95… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Endothelial Dysfunction in Chronic Inflammatory Diseases

International journal of molecular sciences • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…